General Statement of Disclosure:
CONSULTING FEES/HONORARIA: Takeda Pharmaceuticals North America, Inc(SIGNIFICANT), AstraZeneca Pharmaceuticals(MODEST), Altathera Pharmaceuticals(MODEST), Regeneron Pharmaceuticals(SIGNIFICANT) RESEARCH/RESEARCH GRANTS: Bristol-Myers Squibb Company (SIGNIFICANT)